MERTK and leukemia: This concordance between the fraction of cells expressing MERTK and the fraction that are sensitive to UNC2025 implicates on-target MERTK inhibition as a mechanism of MRX-2843/UNC2025 anti-leukemia activity, although MERTK expression data were not available to directly test the concordance in individual samples.